{"cik":1990550,"taxonomy":"us-gaap","tag":"EarningsPerShareBasic","label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","entityName":"Ambrx Biopharma, Inc.","units":{"USD/shares":[{"start":"2022-01-01","end":"2022-09-30","val":-1.74,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13"},{"start":"2022-07-01","end":"2022-09-30","val":-0.4,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2022Q3"},{"start":"2023-01-01","end":"2023-09-30","val":-1.03,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13"},{"start":"2023-07-01","end":"2023-09-30","val":-0.37,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2023Q3"}]}}